• LAST PRICE
    18.1850
  • TODAY'S CHANGE (%)
    Trending Up0.6350 (3.6182%)
  • Bid / Lots
    18.1300/ 3
  • Ask / Lots
    18.2600/ 4
  • Open / Previous Close
    17.9900 / 17.5500
  • Day Range
    Low 17.6100
    High 18.2000
  • 52 Week Range
    Low 9.4000
    High 18.2000
  • Volume
    24,448
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 17.55
TimeVolumePAHC
09:32 ET304417.99
09:34 ET80017.82
09:36 ET30017.81
09:38 ET90017.83
09:41 ET111717.7796
09:43 ET87917.76
09:45 ET90017.61
09:50 ET10017.71
09:52 ET94717.825
09:59 ET140017.98
10:01 ET21217.8001
10:03 ET10017.88
10:08 ET138017.91
10:15 ET10017.95
10:21 ET180018.1
10:24 ET30018.09
10:26 ET30018.0581
10:28 ET213318.01
10:30 ET270018.185
10:32 ET10018.185
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPAHC
Phibro Animal Health Corp
710.8M
56.0x
-13.61%
United StatesPETQ
PetIQ Inc
547.9M
306.2x
---
United StatesSUPN
Supernus Pharmaceuticals Inc
1.6B
-105.1x
-59.02%
United StatesEGRX
Eagle Pharmaceuticals Inc
59.0M
5.1x
-4.75%
United StatesSHWZ
Medicine Man Technologies Inc
48.7M
-0.3x
---
United StatesSGTI
Shengtai Pharmaceutical Inc
10.0
0.0x
---
As of 2024-05-13

Company Information

Phibro Animal Health Corporation is a diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 770 product lines in over 80 countries to approximately 4,000 customers. The Company has three segments. Animal Health segment develops, manufactures and markets about 270 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. Mineral Nutrition segment manufactures and markets approximately 420 formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries, predominantly in the United States.

Contact Information

Headquarters
300 Frank W. Burr Blvd. Suite 21, 65 Challenger RoadTEANECK, NJ, United States 07666
Phone
201-329-7300
Fax
302-655-5049

Executives

Chairman of the Board, President, Chief Executive Officer
Jack Bendheim
Chief Financial Officer
Glenn David
Director, President of MACIE Region and General Manager of Israel Operations
Jonathan Bendheim
President, North America Region
Rob Aukerman
Chief Operating Officer
Larry Miller

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$710.8M
Revenue (TTM)
$999.6M
Shares Outstanding
40.5M
Dividend Yield
2.64%
Annual Dividend Rate
0.4800 USD
Ex-Dividend Date
06-05-24
Pay Date
06-26-24
Beta
0.59
EPS
$0.32
Book Value
$6.97
P/E Ratio
56.0x
Price/Sales (TTM)
0.7
Price/Cash Flow (TTM)
14.6x
Operating Margin
5.87%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.